Diverse human VH antibody fragments with bio-therapeutic properties from the Crescendo Mouse-Reference-Cited by-同舟云学术

Diverse human VH antibody fragments with bio-therapeutic properties from the Crescendo Mouse

Published:2020-03 Issue: Volume:55 Page:65-76
ISSN:1871-6784
Container-title:New Biotechnology
language:en
Short-container-title:New Biotechnology

Author:

Teng Yumin,Young Joyce L.,Edwards Bryan,Hayes Philip,Thompson Lorraine,Johnston Colette,Edwards Carolyn,Sanders Yun,Writer Michele,Pinto Debora,Zhang Yanjing,Roode Mila,Chovanec Peter,Matheson Louise,Corcoran Anne E.,Fernandez Almudena,Montoliu Lluis,Rossi Beatrice,Tosato Valentina,Gjuracic Kresimir,Nikitin Dmitri,Bruschi Carlo,McGuinness Brian,Sandal Thomas,Romanos Mike

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Bioengineering,Biotechnology

Reference57 articles.

1. The increasingly human and profitable monoclonal antibody market;Grilo;Trends Biotechnol,2019

2. A repertoire of monoclonal antibodies with human heavy chains from transgenic mice;Brüggemann;Proc Natl Acad Sci USA,1989

3. Antigen-specific human antibodies from mice comprising four distinct genetic modifications;Lonberg;Nature,1994

4. Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes;Macdonald;Proc Natl Acad Sci USA,2014

5. Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice;Murphy;Proc Natl Acad Sci USA,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Solving selectivity issues in LBAs: case study using Gyrolab to quantify CB307, a bispecific Humabody in human serum;Bioanalysis;2024-07-03

2. Phage display technology and its impact in the discovery of novel protein-based drugs;Expert Opinion on Drug Discovery;2024-06-18

3. Design of Crosslinking Antibodies For T-Cell Activation: Experimental and Computational Analysis of PD-1/CD137 Bispecific Agents;The AAPS Journal;2024-06-11

4. Generation of nanobodies from transgenic ‘LamaMice’ lacking an endogenous immunoglobulin repertoire;Nature Communications;2024-06-03

5. CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors;Clinical Cancer Research;2024-04-09